A CDSCO gynaecological medical device license is mandatory under India's Medical Devices Rules, 2017 for any manufacturer or importer of notified gynaecological devices — including colposcopes, cardiotocographs, birthing equipment, fallopian tube intervention devices, and contraceptive devices. Gynaecological devices span Class A through Class D. Manufacturing Class A and B devices requires a Form MD5 license from the State Licensing Authority (fee: Rs. 5,000 plus Rs. 500 per device). Manufacturing Class C and D devices requires a Form MD9 license from CDSCO Central (fee: Rs. 50,000 plus Rs. 1,000 per device). Importing any class requires a Form MD15 import license from CDSCO. All three license types are valid indefinitely, subject to a retention fee paid every 5 years — non-payment results in automatic cancellation. Applications are submitted through the CDSCO SUGAM portal (cdscoonline.gov.in). ISO 13485 certification and a comprehensive Device Master File are mandatory for all manufacturing license applications.
Gynaecology is the branch of medicine concerned with the health of the female reproductive system — encompassing diagnosis, monitoring, and treatment across obstetrics, reproductive endocrinology, oncogynecology, and general reproductive health. The medical devices that support this clinical discipline range from fundamental birthing and delivery equipment to sophisticated endoscopic systems, foetal monitoring devices, and interventional tools used in minimally invasive gynaecological surgery. Across this spectrum, gynaecological medical devices carry a significant clinical responsibility: they support some of the most medically sensitive moments in a woman's healthcare journey, from routine reproductive health screening to high-acuity obstetric care.
India's gynaecological healthcare landscape is undergoing substantial transformation. Government-led maternal health initiatives, expanding private obstetrics and gynaecology services, rising awareness of reproductive health and cervical cancer screening, and a growing urban and semi-urban middle class seeking higher standards of maternal care are all driving demand for both the devices and the infrastructure that support quality gynaecological care. For manufacturers and importers entering this sector, understanding CDSCO's licensing framework — the classification system, the applicable license types, and the document and application requirements — is the essential foundation for a compliant, commercially successful market entry in India.
📑 Quick Navigation
- Demand for Gynaecological Medical Devices in India
- CDSCO Regulations: Why Mandatory Compliance Matters
- CDSCO Classification: Gynaecological Devices by Class
- Mandatory Documents for CDSCO Gynaecological Device License
- Three CDSCO License Types: MD5, MD9, MD15
- 5-Step Application Process Through CDSCO SUGAM
- License Validity and Retention Fee Requirements
- 5 Benefits of CDSCO Licensing for Gynaecological Device Manufacturers
- How Rego Services Supports Your CDSCO Application
- Frequently Asked Questions
Demand for Gynaecological Medical Devices in India
India's gynaecological medical device market is being shaped by a powerful confluence of demographic, policy, and healthcare quality trends. The country's large and young female population, combined with a sustained government focus on maternal and reproductive healthcare, is generating expanding demand for gynaecological devices at every tier of the healthcare system — from primary care facilities conducting routine screening to tertiary referral centres managing complex obstetric emergencies and gynaecological malignancies.
Government programmes including Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA), the Janani Suraksha Yojana (JSY), and national initiatives for cervical cancer screening and prevention have structurally increased the demand for foetal monitoring systems, colposcopes, and obstetric equipment in government healthcare facilities. In parallel, the rapid expansion of private obstetrics and gynaecology services into tier-2 and tier-3 cities is driving procurement of a wider range of gynaecological devices — from high-specification delivery suites to flexible fibreoptic hysteroscopes and endometrial assessment tools — by private hospitals and maternity centres that are competing on clinical quality and patient experience.
Rising awareness of cervical cancer — India accounts for a substantial share of the global cervical cancer burden — is increasing demand for colposcopes, cervical biopsy equipment, and cytology tools used in early detection and screening. Simultaneously, the growing adoption of minimally invasive gynaecological surgery is driving demand for flexible fibreoptic and video laparoscopes, hysteroscopes, salpingoscopes, and associated interventional equipment. For device companies entering this segment with a valid CDSCO license, the addressable market spans government tender procurement, private hospital capital equipment, and ongoing consumable supply across a diverse range of gynaecological specialities.
CDSCO Regulations: Why Mandatory Compliance Matters
The clinical environment in which gynaecological medical devices are used — obstetric care, reproductive surgery, foetal monitoring, and cancer screening — places these devices in a category where device failure, substandard performance, or contamination can have serious and sometimes irreversible consequences for the patient. The consequences of a malfunctioning cardiotocograph that fails to correctly identify foetal distress, or a defective colposcope that delivers a poor-quality image in a cervical cancer screening procedure, extend directly to patient outcomes in clinically critical situations.
CDSCO's regulatory framework for gynaecological medical devices under the Medical Devices Rules, 2017 is built on this recognition. By requiring manufacturers and importers to obtain a CDSCO license, demonstrate ISO 13485-certified quality management systems, and submit comprehensive Device Master Files with performance and safety data, CDSCO ensures that every notified gynaecological device entering the Indian market has been assessed against a defined quality and safety standard. For manufacturers and importers, this means a valid CDSCO license is not a discretionary compliance step — it is a mandatory legal prerequisite for placing gynaecological devices on the Indian market.
CDSCO Classification: Gynaecological Devices by Class
The Medical Devices Rules, 2017 classify all notified medical devices into four risk-based classes — A (lowest risk) through D (highest risk). For gynaecological devices, this classification system spans the full risk spectrum, reflecting the diversity of the device category — from non-invasive environmental equipment used in the delivery suite to permanently implanted devices. Understanding the class of your specific device is the mandatory first step that determines which license form to use, which authority issues the license, and the fee structure that applies.
- Abdominal decompression chamber
- Abdominal decompression chamber pump
- Birthing bed / table, powered
- Amniotic membrane perforator, reusable
- Birthing / delivery kit
- Heel stirrup
- Gynaecological operating table — electrohydraulic, electromechanical or hydraulic
- Abortion suction system / manual aspirator
- Cervical anaesthesia kit / needle (reusable or single use)
- Endocervical aspirator
- Endocervical specimen collection kit (no additive)
- Endometrial biopsy curette / kit / cytology brush
- Fallopian tube biopsy everting-balloon catheter
- Fallopian tube catheterization kit
- Fallopian tube insufflator
- Fixed-diameter cervical dilator (reusable or single use)
- Flexible fibreoptic culdoscope / hysteroscope / laparoscope
- Flexible fibreoptic mammary ductoscope / salpingoscope
- Flexible ultrasound laparoscope
- Flexible video culdoscope / hysteroscope / laparoscope
- Flexible video mammary ductoscope / salpingoscope
- Foetal Doppler system
- Cardiotocograph
- Cardiotocograph transducer
- Cardiotocography telemetric monitoring system (and receiver / transmitter)
- Colposcope
- Contraceptive cervical cap (reusable or single use)
- Contraceptive spermicide
- Contraceptive sponge
- Diaphragm pessary
- Breast transilluminator
- Fallopian tube occlusion insert
Mandatory Documents for CDSCO Gynaecological Device License Application
To apply for a CDSCO gynaecological medical device license, applicants must compile a defined set of supporting documents. The quality, completeness, and internal consistency of this document set is the primary factor that determines how efficiently the application progresses through CDSCO review — and, for higher-risk Class C and D devices, through expert committee scrutiny and facility inspection.
- Organisation identity proof — Certificate of Incorporation, Memorandum and Articles of Association, GST registration certificate, and other applicable documents establishing the legal identity and standing of the applicant company. All documents must consistently reflect the same registered entity name and address.
- Sale Deed or Rent Deed of the premises — Valid documentary evidence confirming the applicant's legal right to occupy the declared manufacturing premises. The address on this document must match precisely the facility address declared in the Plant Master File and on the SUGAM application form.
- Building layout with dimensions — An accurate, dimensioned floor plan of the manufacturing facility showing all production areas, quality control laboratory, raw material and finished-goods storage zones, personnel areas, and product flow routes — prepared in accordance with CDSCO requirements. For devices requiring specific environmental controls (cleanrooms for sterile gynaecological devices), the layout must clearly indicate controlled area zones.
- Plant Master File (PMF) — A comprehensive document describing the manufacturing facility: location, layout, equipment list and calibration records, manufacturing process flows, environmental monitoring provisions, quality control procedures, personnel structure, GMP compliance infrastructure, and storage conditions. For Class C gynaecological devices such as cardiotocographs and colposcopes, the PMF must demonstrate rigorous GMP compliance and appropriate test and calibration equipment for the device category.
- Device Master File (DMF) — The comprehensive technical dossier for the gynaecological device: device description and intended use, design documentation, materials specification and biocompatibility assessment (ISO 10993 where relevant), manufacturing process description, risk management file under ISO 14971, performance and safety testing data against applicable standards (IEC 60601-1, IEC 60601-2-57 for laser-based devices, etc.), software validation records where the device incorporates software functions, labelling and Instructions for Use, and post-market surveillance plan. For Class C monitoring devices such as cardiotocographs, the DMF must address signal accuracy, alarm performance, and telemetric system reliability with supporting test data.
- Documents for the team of qualified and experienced staff — Curriculum vitae, educational qualifications, appointment letters, and training records for personnel responsible for manufacturing and testing the gynaecological devices, demonstrating CDSCO's minimum qualification requirements are met for technical and quality roles.
- Environmental regulation compliance documents — Applicable Pollution Control Board No-Objection Certificate and waste disposal documentation. This is particularly relevant where manufacturing processes generate regulated waste streams, including chemical waste from cleaning processes or biological waste from product testing involving biological materials.
- ISO 13485 Certificate — A current, valid certificate from an IAF-accredited certification body, with scope explicitly covering the manufacturing activities relevant to the gynaecological device being licensed. For sterile gynaecological device manufacturers, the scope must specifically include sterile medical device manufacturing.
- Certificate of Analysis for 3 consecutive production batches — Laboratory analysis and performance test results demonstrating that three sequential production batches consistently meet all declared specifications. For first-time manufacturers, these batches must be produced under a valid CDSCO MD13 test license before the MD5 or MD9 application can proceed.
- Test License (if required) — Where initial production batches were manufactured under an MD13 test license prior to the permanent license application, a copy of that license must be included as a supporting document contextualising the submitted batch data.
For Class C gynaecological devices — cardiotocographs, colposcopes, contraceptive devices, and telemetric foetal monitoring systems — and the sole Class D device (fallopian tube occlusion insert), the Device Master File receives the most intensive CDSCO scrutiny. For the fallopian tube occlusion insert specifically, the biocompatibility data, long-term safety evidence, and risk management documentation must be of the depth appropriate for a permanently implanted device. Manufacturers should ensure these sections of the DMF are prepared with specialist input and are fully supported by testing data from accredited laboratories.
CDSCO Medical Device Test License (MD13 / MD17) India 2026 — Complete Guide
If you are a first-time manufacturer of gynaecological medical devices, you will need to produce a Certificate of Analysis for three consecutive production batches before applying for the MD5 or MD9 permanent manufacturing license. An MD13 test license is the legally required prerequisite for manufacturing these batches. This guide covers the complete test license process — mandatory documents, the SUGAM application, and validity rules.
Three CDSCO License Types: MD5, MD9, MD15
Three distinct CDSCO license types apply to gynaecological medical devices — determined by whether the applicant is manufacturing or importing, and, for manufacturers, the risk class of the specific device.
Manufacturing Class A and B gynaecological devices — such as birthing beds, delivery kits, fallopian tube catheterisation kits, and flexible fibreoptic endoscopes — requires an MD5 license from the State Licensing Authority of the state in which the facility is located, with a base fee of Rs. 5,000 plus Rs. 500 per distinct device. Manufacturing Class C and D gynaecological devices — such as cardiotocographs, colposcopes, contraceptive devices, and the fallopian tube occlusion insert — requires an MD9 license from CDSCO's Central Licensing Authority, with a base fee of Rs. 50,000 plus Rs. 1,000 per distinct device. Importing gynaecological devices of any class into India requires an MD15 import license from CDSCO regardless of the device's risk class.
5-Step Application Process Through CDSCO SUGAM
The CDSCO gynaecological medical device license application follows a defined five-step process, filed entirely through the CDSCO SUGAM online portal at cdscoonline.gov.in. Selecting the correct form — MD5, MD9, or MD15 — based on the confirmed device classification is a prerequisite to beginning the application.
Compile all mandatory supporting documents: organisation identity proof, Sale Deed or Rent Deed of the premises, dimensioned building layout, Plant Master File, Device Master File, qualified personnel documentation, environmental compliance certificates, Certificate of Analysis for three consecutive batches, ISO 13485 certificate, and MD13 test license where applicable. Every document must be internally consistent — the intended use in the DMF must match Form MD5/MD9/MD15 exactly, the facility layout must match the PMF, and personnel records must align with the qualifications declared in the application. Inconsistencies between documents are the most common source of CDSCO reviewer queries for gynaecological device applications.
File the application online at cdscoonline.gov.in, selecting the applicable license form — MD5 (Class A/B manufacture), MD9 (Class C/D manufacture), or MD15 (import all classes). Complete all fields accurately, attach all supporting documents in the specified file formats and within the portal's size limits, and pay the applicable government fee. Fee payment formally submits the application — prior to payment, it remains in draft status and has not been received by the licensing authority for review. Retain the application reference number generated on submission for all subsequent correspondence.
CDSCO may raise written queries on the submitted application and documents through the SUGAM portal — typically relating to the Device Master File's technical content, the ISO 13485 certificate's scope coverage, or the completeness of batch Certificate of Analysis data. For Class C devices such as cardiotocographs and colposcopes, queries relating to performance testing data and device accuracy specifications are common. All queries must be addressed promptly, accurately, and with supporting evidence through the portal. Assign a regulatory lead to monitor the SUGAM portal daily for query notifications, since response timelines directly affect the overall application timeline.
For MD5 and MD9 manufacturing license applications, CDSCO regulatory officials may conduct a facility inspection to verify that the manufacturing processes, quality management systems, personnel qualifications, and facility infrastructure declared in the Plant Master File and Device Master File are accurate and operationally in place. For Class C gynaecological device manufacturers — particularly those producing cardiotocographs, colposcopes, or telemetric monitoring systems — the inspection will cover calibration records for test equipment, software validation evidence, and GMP compliance across the manufacturing process. Conduct a rigorous pre-inspection internal audit using the PMF as the inspection checklist.
Once all CDSCO criteria are satisfied — all documents verified, queries resolved, and inspection findings (where applicable) cleared — the applicable gynaecological medical device license is granted through the SUGAM portal: Form MD5, MD9, or MD15. Review the license details carefully on receipt to confirm that every device name, facility address, and applicant entity name is accurately reflected. Any discrepancies should be flagged to the issuing authority immediately for correction before commencing commercial manufacture or import activity under the license.
License Validity and Retention Fee Requirements
The CDSCO gynaecological medical device license is valid indefinitely from the date of grant — there is no fixed expiry date on the license itself. This indefinite validity provides long-term regulatory stability for manufacturers and importers who have built their commercial operations around a licensed gynaecological device portfolio.
| Parameter | MD5 — Class A/B Manufacture | MD9 — Class C/D Manufacture | MD15 — Import All Classes |
|---|---|---|---|
| Validity | Indefinite | Indefinite | Indefinite |
| Retention fee cycle | Every 5 years | Every 5 years | Every 5 years |
| Effect of non-payment | Automatic cancellation | Automatic cancellation | Automatic cancellation |
| Issuing authority | State Licensing Authority | CDSCO (Central) | CDSCO (Central) |
| Initial license fee | Rs. 5,000 + Rs. 500/device | Rs. 50,000 + Rs. 1,000/device | Class-dependent |
5 Benefits of CDSCO Licensing for Gynaecological Device Manufacturers
A valid CDSCO license is the legal gateway to India's gynaecological medical device market — a market structurally driven by maternal health policy, rising reproductive health awareness, growing surgical volumes, and an expanding private obstetrics and gynaecology sector. Without a valid CDSCO license, neither manufacture nor import of notified gynaecological devices is legally permissible in India. Obtaining the license converts growing market demand into legally accessible commercial opportunity.
Gynaecologists, obstetricians, and hospital procurement teams are clinically sensitive to the quality of devices used in maternal and reproductive care settings. CDSCO licensing — backed by ISO 13485 quality management certification and comprehensive Device Master File documentation — signals that a manufacturer's colposcopes, cardiotocographs, or fallopian tube devices have been assessed against a verified safety and quality standard, supporting trust-based commercial relationships in a clinically critical specialty.
India's maternal health initiatives — including PM Surakshit Matritva Abhiyan, JSY, and national cervical cancer screening programmes — procure gynaecological devices through government and empanelled facility channels. CDSCO licensing is a mandatory eligibility requirement for government procurement participation. Manufacturers with a valid MD5 or MD9 license gain access to this substantial public procurement channel, while unlicensed competitors are excluded regardless of product quality.
Gynaecological devices imported without a valid CDSCO MD15 license face customs detention and potential seizure. For healthcare facilities dependent on reliable supplies of foetal monitoring consumables, colposcopy accessories, or endoscopic components, customs delays directly affect clinical operations. A valid MD15 license ensures consistent, uninterrupted customs clearance — protecting the supply continuity that hospital procurement departments and clinical teams depend on.
Gynaecological device demand in India is structurally durable — driven by demographic growth, expanding healthcare access, and sustained government investment in maternal health that is independent of economic cycles. A CDSCO license with indefinite validity provides the long-term regulatory foundation from which manufacturers can grow their gynaecological device portfolio — adding new endoscopic products, monitoring systems, or interventional devices to the license through variation applications as the business scales.
CDSCO General Hospital Medical Device License India 2026 — Complete Guide
Gynaecological device manufacturers whose portfolio also includes general hospital equipment — patient monitoring systems, surgical tables, sterilisation equipment, or infusion devices used across clinical departments — should review the CDSCO licensing requirements for the general hospital device category. These requirements apply alongside gynaecology-specific licensing and may enable consolidation of multi-category product portfolios under a coordinated licensing strategy.
How Rego Services Supports Your CDSCO Application
Securing the CDSCO gynaecological medical device license is a substantial undertaking — particularly for Class C devices such as cardiotocographs and colposcopes, and for the Class D fallopian tube occlusion insert, where the technical depth of the Device Master File and the intensity of the Central Licensing Authority review require considerable regulatory expertise. Rego Services Private Limited provides end-to-end support for CDSCO gynaecological medical device license applications across all device classes and all three license types.
- Device classification confirmation and licensing strategy — We confirm the CDSCO class of your specific gynaecological device configuration, identify the correct license type (MD5, MD9, or MD15), and assess whether an MD13 test license is required before the permanent license application — structuring the pathway correctly from the outset.
- ISO 13485 certification support — Where ISO 13485 certification is not yet in place, we support the full certification process — QMS gap analysis, documentation development, implementation support, and certification body coordination — on a timeline aligned with the CDSCO license application, with scope language correctly covering the gynaecological device manufacturing activities.
- Device Master File preparation — We prepare CDSCO-compliant Device Master Files for gynaecological devices across all classes, with particular attention to the performance and safety testing data for Class C monitoring devices (cardiotocographs, cardiotocography telemetric systems), the biocompatibility documentation for devices with body contact, and the implant safety evidence required for Class D fallopian tube occlusion insert applications.
- Plant Master File preparation — We prepare Plant Master Files that accurately describe the manufacturing facility in the level of detail CDSCO reviewers and inspectors expect, including GMP compliance evidence, equipment calibration records, and process validation documentation appropriate for the risk class of the gynaecological device being licensed.
- Batch production and Certificate of Analysis support — We support the planning, documentation, and coordination of the three consecutive production batch runs and their performance testing required as mandatory evidence for MD5 and MD9 applications.
- SUGAM portal submission management — We manage the complete online application process — form selection, field completion, document upload in the correct format, fee payment coordination, and formal submission — eliminating procedural errors that delay the review clock starting.
- Query response and facility inspection preparation — We draft responses to CDSCO reviewer and expert committee queries, and prepare manufacturing facilities for CDSCO inspection through mock inspection exercises that reflect documented inspection patterns for gynaecological device applications across all device classes.
- Post-grant compliance and retention fee management — We maintain retention fee compliance calendars and support ongoing CDSCO compliance after license grant, helping manufacturers and importers avoid the automatic cancellation risk associated with missed retention fee deadlines, and managing license variation applications as product portfolios expand.
Frequently Asked Questions
Why is the fallopian tube occlusion insert classified as Class D — the highest CDSCO risk category?
The fallopian tube occlusion insert is classified as Class D because it is a permanently implanted device designed to remain in the body indefinitely, with its entire clinical function dependent on sustained engagement with the fallopian tube tissue. As a permanently implanted contraceptive device, any failure in its design, materials, or biocompatibility carries consequences — including contraceptive failure or long-term adverse tissue response — that cannot be readily reversed. This combination of permanent implantation, sustained internal tissue contact, and irreversibility places it in CDSCO's highest risk tier, requiring an MD9 license from the Central Licensing Authority and the most rigorous documentation, including comprehensive long-term biocompatibility and clinical safety data in the Device Master File.
Can a single MD9 license cover multiple Class C gynaecological devices — for example, a cardiotocograph and a colposcope?
Yes. A single MD9 license can cover multiple Class C and D gynaecological devices, provided each product is separately declared in the Form MD9 application and the Device Master File contains a product-specific section for each device — since a cardiotocograph (a foetal monitoring system) and a colposcope (a cervical visualisation system) are entirely different devices with different intended uses, performance specifications, and applicable standards. Each additional device declared in the application attracts the per-device fee of Rs. 1,000. Adding new Class C or D gynaecological devices after the initial MD9 is granted requires a variation application to CDSCO Central, not a fresh license application.
Does importing flexible fibreoptic laparoscopes for gynaecological use require the same MD15 license as importing a cardiotocograph?
Yes — both require a valid MD15 import license from CDSCO regardless of their different risk classes (the flexible fibreoptic laparoscope is Class B; the cardiotocograph is Class C). However, since different classes carry different fee structures under the MD15 pathway, confirm the applicable fee for each specific device before submitting the import license application. If your import portfolio spans multiple gynaecological device types and classes, all devices can be covered under a single MD15 license provided each is declared as a separate product entry with its own product-specific documentation.
What performance testing standards apply to cardiotocographs for the CDSCO MD9 application?
Cardiotocographs used for foetal heart rate and uterine contraction monitoring must comply with applicable IEC and ISO standards referenced under MDR 2017, including IEC 60601-1 (General requirements for basic safety and essential performance of medical electrical equipment), IEC 60601-1-2 (EMC requirements), and IEC 60601-2-55 (Particular requirements for the basic safety and essential performance of respiratory gas monitors) where applicable, alongside foetal monitor-specific performance standards. Testing must be performed by accredited testing laboratories, and the test reports must be included in the Device Master File submitted with the MD9 application. Rego Services advises on the current applicable standards for each Class C gynaecological device category as part of the DMF preparation process.
How does CDSCO's cervical cancer screening initiative affect manufacturers of colposcopes and cervical assessment devices?
National initiatives to expand cervical cancer screening coverage in India are directly increasing government procurement of colposcopes, cervical cytology tools, and associated diagnostic equipment. For manufacturers holding a valid MD9 license for Class C colposcopes, this creates access to a growing public health procurement channel — government hospitals, district screening programmes, and empanelled gynaecology centres — that is exclusively available to CDSCO-licensed manufacturers. For companies entering the cervical cancer screening equipment space, obtaining the MD9 license early is critical to capturing this procurement pipeline as it expands.
✓ Key Takeaways
- Demand for gynaecological medical devices in India is rising sharply, driven by maternal health government programmes, cervical cancer screening initiatives, expanding private obstetrics services, and growing reproductive health awareness
- Gynaecological devices span all four CDSCO risk classes — from birthing tables and delivery kits (Class A) through fallopian tube catheters and flexible endoscopes (Class B), colposcopes and cardiotocographs (Class C), to fallopian tube occlusion inserts (Class D)
- Three license types apply: MD5 (manufacture Class A/B — State Licensing Authority, Rs. 5,000 + Rs. 500/device), MD9 (manufacture Class C/D — CDSCO Central, Rs. 50,000 + Rs. 1,000/device), and MD15 (import all classes — CDSCO Central)
- All three license types are valid indefinitely — but the retention fee must be paid every 5 years, or the license is automatically cancelled without the possibility of reinstatement through late payment
- ISO 13485 certification and a comprehensive Device Master File — with particular emphasis on performance testing data for Class C monitoring and diagnostic devices and biocompatibility / long-term safety evidence for the Class D implant — are mandatory for all manufacturing license applications
- The CDSCO application process follows 5 structured steps: document preparation, SUGAM portal submission, query resolution, facility inspection (for manufacturing licenses), and license approval
- First-time manufacturers needing initial batch data will require an MD13 test license before applying for the permanent MD5 or MD9 license — this must be factored into the overall regulatory timeline
- A single MD5 or MD9 license can cover multiple gynaecological devices across the applicable class — new products added after license grant require a variation application to the issuing authority
Your Next Step
Gynaecological medical devices occupy a clinically and commercially important position in India's healthcare system — serving a large, growing patient population across obstetrics, reproductive health, gynaecological oncology, and minimally invasive surgery. The CDSCO licensing framework reflects this importance: the classification system is detailed, the document requirements are demanding, and the license type and issuing authority are determined by the specific risk class of each device. For manufacturers and importers approaching this market, getting the regulatory pathway right from the outset — confirming device classification, structuring the license application correctly, and preparing comprehensive, consistent documentation — is the foundation of a compliant, efficient market entry.
Rego Services' regulatory team brings deep familiarity with CDSCO's requirements across the full gynaecological device spectrum — from Class A delivery kits through Class C cardiotocographs and colposcopes to the Class D fallopian tube occlusion insert. With our support, the path from device classification through ISO 13485 certification, Device Master File and Plant Master File preparation, SUGAM portal submission, and license grant is a structured, well-managed process rather than the complex and time-consuming challenge it can be without experienced regulatory guidance.
Contact Rego Services today to confirm your gynaecological device's CDSCO classification, identify the correct license type, and receive a device-specific regulatory plan with a realistic timeline for your India market entry.